Firefly Neuroscience (AIFF) FCF Margin (2010 - 2026)
Firefly Neuroscience (AIFF) posted FCF Margin of 348.64% for Q2 2026, up 15.71% on a QoQ basis from 413.61% in Q1 2026, and up 45471.0% year-over-year from N/an in Q2 2025.
Analysis
Firefly Neuroscience (AIFF) FCF Margin (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported FCF Margin for 16 years, with the latest figure at 348.64% in Q2 2026.
- On a quarterly basis, FCF Margin rose 45471.0% year-over-year to 348.64% in Q2 2026; TTM through Jun 2026 was 400.22%, a 256088.0% increase from a year earlier, with the FY2025 full-year figure at 728.72%, up 510739.0% from the prior year.
- FCF Margin was 348.64% for Q2 2026 at Firefly Neuroscience, up from 413.61% in the prior quarter.
- The five-year high for FCF Margin was 2137.11% in Q3 2023, with the low at 11281.82% in Q2 2024.
- Average FCF Margin over 5 years is 2388.82%, with a median of 405.67% recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: FCF Margin slumped 1126260 bps in 2024, then jumped 1047847 bps in 2025.
- Over 5 years, FCF Margin stood at 146.47% in 2022, then tumbled by 1733 bps to 2684.21% in 2023, then slumped by 239 bps to 9100.0% in 2024, then jumped by 95 bps to 443.69% in 2025, then gained by 21 bps to 348.64% in 2026.
- The last three FCF Margin figures came in at 348.64% (Q2 2026), 413.61% (Q1 2026), and 443.69% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 1.28% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 23.15% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 11.63% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -52.87% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -45.84% |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 5.70% |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | -348.64% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -348.64% |
| Mar 31, 2026 | -413.61% |
| Dec 31, 2025 | -443.69% |
| Sep 30, 2025 | -405.67% |
| Jun 30, 2025 | -803.34% |
| Mar 31, 2025 | -5,855.81% |
| Sep 30, 2024 | -9,100.00% |
| Jun 30, 2024 | -11,281.82% |
| Mar 31, 2024 | -10,991.67% |
| Dec 31, 2023 | -2,684.21% |
| Sep 30, 2023 | 2,137.11% |
| Jun 30, 2023 | -19.22% |
| Mar 31, 2023 | -81.68% |
| Dec 31, 2022 | -146.47% |
| Sep 30, 2022 | -41.05% |
| Jun 30, 2022 | -64.75% |
| Mar 31, 2022 | -65.39% |
| Dec 31, 2021 | -13.20% |
| Sep 30, 2021 | -7.98% |
| Jun 30, 2021 | -6.27% |